Leucadia National Corporation »

Maxcyte shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $16k 10k 1.55
2022-12-31 $7.0k 18k 0.38

More positions owned by Leucadia National Corporation

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Iren Ordinary Shares (IREN)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Citigroup Com New (C)
Amazon (AMZN)
Spdr Series Trust State Street Spd (XBI)
Apple (AAPL)
Select Sector Spdr Tr State Street Ene (XLE)
Alphabet Cap Stk Cl A (GOOGL)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)

View all positions for Leucadia National Corporation

Top funds holding Maxcyte

BlackRock
Cadian Capital Management
Mirabella Financial Services
Vanguard Group
Vitruvian Partners
Mudita Advisors
Bnp Paribas Investment Partners
AXA Investment Managers
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Dimensional Fund Advisors
Willis Investment Counsel
Citadel Advisors
Renaissance Technologies

View all funds holding Maxcyte